Abstract
In premenopausal, ovulatory women, estrogen arises by two mechanisms. It is believed that the biologically more important of these is the synthesis of 17β-estradiol in the developing follicle. This obtains since 17β-estradiol is a more potent estrogen than that produced by the second mechanism, i.e., the extraglandular formation of estrone from circulating andro-stenedione. The rate of extraglandular estrone formation does not vary appreciably during the ovarian cycle (Fig. l-l).1 On average, about 3 mg of androstenedione are produced each day in young women and 1.5% of plasma androstenedione is aromatized (the process of converting androgen to estrogen) to estrone in extraglandular tissues.1–4 Thus, approximately 45 μg of estrone arise by this mechanism. At the extremes of the ovarian cycle, this amount of estrone may constitute 50% or more of the total estrogen produced in young women.1 The rate of secretion of 17β-estradiol by the ovary, however, varies widely during the ovarian cycle (Fig. 1-1). It is estimated that the rate of secretion of 17β-estradiol varies from 20–40 μg/day early and late in the cycle to as much as 600–1000 μg/dayjust prior to the midcycle LH (luteinizing hormone) surge and ovulation.1
Supported in part by USPHS Grant No. 2-P01-AG00306.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Siiteri PK, MacDonald PC. Role of extraglandular estrogen in human endocrinology. In: Greep RO, Astwood EB, eds. Handbook of physiology. Washington DC: American Physiology Society, Section 7: Endocrinology, 1963:615–629.
VandeWiele RL, MacDonald PC, Gurpide E, et al. Studies on the secretion and interconversion of the androgens. Rec Prog Horm Res. 1963; 19:275–309.
MacDonald PC, VandeWiele RL., Lieberman S. Precursors of the urinary 11-desoxy-17-ketoste-roids of ovarian origin. Am J Obstet Gynecol. 1963; 86:1–10.
MacDonald PC, Grodin JM, Siiteri PC. Dynamics of androgen and oestrogen secretion. In: Baird D, ed. Gonadal steroid secretion. Edinburgh: Ciba Foundation Symposium, 1971:158–174.
Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab. 1973; 36:207–214.
Longcope C. Metabolic clearance and blood production rates of estrogens in postmenopausal women. Am J Obstet Gynecol. 1971; 111:778–781.
Judd HL, Judd GE, Lucas WE. Endocrine function of the postmenopausal ovary: Concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab. 1974; 39:1020–1024.
MacDonald PC, Edman CD, Kerber IJ, et al. Plasma precursors of estrogen: III. Conversion of plasma dehydroisoandrosterone to estrogen in young, nonpregnant women. Gynecol Invest. 1976; 7:165–175.
MacDonald PC, Madden JD, Brenner PF, et al. Origin of estrogen in normal men and in women with testicular feminization. J Clin Endocrinol Metab. 1979; 49:905–916.
Gurpide E. Hormones and gynecologic cancer. Cancer. 1976; 38(suppl l):503–508.
Longcope C, Layne DS, Tait JF. Metabolic clearance rates and interconversions of estrone and 17β-estradiol in normal males and females. J Clin Invest. 1968; 47:93–106.
Schindler AE, Ebert A, Friedrich E. Conversion of androstenedione to estrone by human fat tissue. J Clin Endocrinol Metab. 1972; 35:627–630.
Bolt HM, Gobel P. Formation of estrogens from androgens by human subcutaneous adipose tissue in vitro. Horm Metab Res. 1972; 4:312–313.
Nimrod A, Ryan KJ. Aromatization of androgens by human abdominal and breast fat tissue. J Clin Endocrinol Metab. 1975; 40:367–372.
Perel E, Killinger DW. The interconversion and aromatization of androgens by human adipose tissue. J Steroid Biochem. 1979; 10:623–627.
Schweikert HU, Milewich L, Wilson JD. Aromatization of androstenedione by cultured human fibroblasts. J Clin Endocrinol Metab. 1976; 43:785–795.
Schweikert HU, Milewich L, Wilson JD. Aro-matization of androstenedione by isolated human hairs. J Clin Endocrinol Metab. 1975; 40:413–417.
Naftolin F, Ryan K, Petro Z. Aromatization of androstenedione by the diencephalon. J Clin Endocrinol Metab. 1971; 33:368–370.
Frisch RE, Canick JA, Tulchinsky D. Human fatty marrow aromatizes androgen to estrogen. J Clin Endocrinol Metab. 1980; 51:394–396.
Longcope C, Pratt JH, Schneider SH, et al. Aromatization of androgens by muscle and adipose tissue in vivo. J Clin Endocrinol Metab. 1978; 46:146–152.
Perel E, Wilkins D, Killinger DW. The conversion of androstenedione to estrone, estradiol, and testosterone in breast tissue. J Steroid Biochem. 1980; 13:89–94.
Schweikert HU. Conversion of androstenedione to estrone in human fibroblasts cultured from prostate, genital and nongenital skin. Horm Metab Res. 1979; 11:635–640.
Maclndoe JH. Estradiol formation from testosterone by continuously cultured human breast cancer cells. J Clin Endocrinol Metab. 1979; 49:272–277.
MacDonald PC, Grodin JM, Edman CD, et al. Origin of estrogen in a postmenopausal woman with a nonendocrine tumor of the ovary and endometrial hyperplasia. Obstet Gynecol. 1976; 47:644–650.
Aiman EJ, Nalick RH, Jacobs A, et al. The origin of androgen and estrogen in a virilized postmenopausal woman with bilateral benign cystic teratomas. Obstet Gynecol. 1977; 49:695–704.
Aiman EJ, Edman CD, Worley RJ, et al. Androgen and estrogen formation in women with ovarian hyperthecosis. Obstet Gynecol. 1978; 51:1–9.
Klyde BJ, Hirsch J. Increased cellular proliferation in adipose tissue of adult rats fed a high fat diet. J Lipid Res. 1979; 20:705–715.
Klyde BJ, Hirsch J. Isotopic labeling of DNA in rat adipose tissue for proliferating cells associated with mature adipocytes. J Lipid Res. 1979; 20:691–704.
Siiteri PK, Williams JE, Takaki NK. Steroid abnormalities in endometrial and breast carcinoma: A unifying hypothesis. J Steroid Biochem. 1976; 7:897–903.
Ackerman GE, Smith ME, Mendelson CR, et al. Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J Clin Endocrinol Metab. 1981; 412–417.
Mendelson CR, Cleland WH, Smith ME, et al. Regulation of aromatase activity of stromal cells derived from human adipose tissue. Endocrinology. 1982; 1077–1085.
Hemsell DL, Grodin JM, Brenner PF, et al. Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab. 1974; 38:476–479.
MacDonald PC, Edman CD, Hemsell DL, et al. Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol 1978; 130:448–455.
Wynder EL, Fisher GC, Mantel N. An epidemiological investigation of cancer of the endometrium. Cancer. 1966; 19:489–520.
Speert H. Endometrial cancer and hepatic cirrhosis. Cancer. 1949; 2:597–603.
Apperly FL. Endometrial hyperplasia in elderly women with hepatic cirrhosis. Va Med Monthly. 1951; 78:602.
Gordon GG, Olivo J, Rafii F, et al. Conversion of androgens to estrogens in cirrhosis of the liver. J Clin Endocrinol Metab. 1975; 40:1018–1026.
Edman CD, MacDonald PC, Combes B. Ex-traglandular production of estrogen in subjects with liver disease. Gastroenterology. 1975; 69:819.
Rivarola MA, Singleton RT, Mignon CJ. Splanchnic extraction and interconversion of testosterone and androstenedione in man. J Clin Invest. 1967; 46:2096–2100.
Edman CD, MacDonald PC. Extraglandular aromatization—primarily an extrahepatic metabolic process. Gynecol Invest. 1977; 8:50.
Edman CD, MacDonald PC. The role of extraglandular estrogen in women in health and disease. In: James VHT, Serio M, Gusti, G, eds. The endocrine function of the human ovary. London: Academic Press, 1976:135–140.
Southern AL, Olivo J, Gordon GG, et al. The conversion of androgens to estrogens in hyper-thyroidism. J Clin Endocrinol Metab. 1974; 38:207–214.
Hemsell DL, Edman CD, Marks JF, et al. Massive extraglandular aromatization of plasma androstenedione resulting in feminization of a prepubertal boy. J Clin Invest. 1977; 60:455–464.
MacDonald PC. Determinants of the rate of estrogen formation in postmenopausal women. Eur J Obstet Gynaecol Reprod Biol. 1979; 9/3:187–189.
Silverberg SG. Brenner tumor of the ovary. A clinical study of 60 tumors in 54 women. Cancer. 1971; 28:588–596.
Wren BG, Frampton J. Oestrogenic activity associated with nonfeminizing ovarian tumors after the menopause. Br Med J. 1963; 2:842–844.
Wilkinson EJ, Friedrich EG, Mattingly RF. Turner’s syndrome with endometrial adenocar-cinoma and stilbestrol therapy. Obstet Gynecol. 1973; 42:193–200.
Cutler BS, Forbes AP, Ingersoll FM, et al. Endometrial carcinoma after stilbestrol therapy. N Engl J Med. 1972; 287:628–631.
Dewhurst CJ, deKoos EB, Haines RM. Replacement hormone therapy in gonadal dysgenesis. Br J Obstet Gynaecol. 1975; 82:412–416.
McCarroll AM, Montgomery DAD, Harley JMG, et al. Endometrial carcinoma after cyclical oestrogen-progestogen therapy for Turner’s syndrome. Br J Obstet Gynaecol. 1975; 82:421–425.
Roberts G, Wells AL: Oestrogen-induced endometrial carcinoma in a patient with gonadal dysgenesis. Br J Obstet Gynaecol. 1975; 82:417–420.
Sirota DK, Marinoff SC. Endometrial carcinoma in Turner’s syndrome following prolonged treatment with diethylstilbestrol. Mt Sinai J Med. 1975; 42:586–590.
Silverberg SG, Makowski EL. Endometrial carcinoma in young women taking oral contraceptive agents. Obstet Gynecol. 1975; 46:503–506.
Fechner RE, Kaufman RH. Endometrial ade-nocarcinoma in Stein-Leventhal syndrome. Cancer. 1974; 24:444–452.
Jackson RL, Dockerty MB. The Stein-Leventhal syndrome: Analysis of 43 cases with special reference to association with endometrial carcinoma. Am J Obstet Gynecol. 1957; 73:161–173.
Edman CD, MacDonald PC. Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulatory young women. Am J Obstet Gynecol. 1978; 130:456–461.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Casey, M.L., MacDonald, P.C. (1983). Origin of Estrogen and Regulation of Its Formation in Postmenopausal Women. In: Buchsbaum, H.J. (eds) The Menopause. Clinical Perspectives in Obstetrics and Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-5525-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4612-5525-3_1
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-5527-7
Online ISBN: 978-1-4612-5525-3
eBook Packages: Springer Book Archive